Advances in Lung Cancer

Volume 11, Issue 2 (June 2022)

ISSN Print: 2169-2718   ISSN Online: 2169-2726

Citations  

Association between the DNA Repair Gene Polymorphisms and Lung Cancer in Turkish Population

HTML  XML Download Download as PDF (Size: 321KB)  PP. 15-29  
DOI: 10.4236/alc.2022.112002    130 Downloads   826 Views  

ABSTRACT

Introduction: DNA repair enzymes continuously monitor DNA to correct damaged nucleotide residues generated by exposure to environmental mutagenic and cytotoxic compounds or carcinogens. Our objective was to investigate the association among XRCC1 (Arg399Gln and Arg194Trp), XRCC3 (Thr241Met), XPD-ERCC2 (Lys751Gln), APE1 (Asp241Glu), PARP-ADPRT (Val762Ala) DNA repair gene polymorphisms and lung cancer in Turkish population. Materials and Methods: Our patient group consists of 90 patients with lung cancer and the control group had 100 healthy individuals all of those smoking. DNA was extracted using the whole blood samples. PCR- RFLP technique was used to investigate the polymorphisms on target genes. Results: There was no significant difference in the genotype distributions of XPD Lys751Gln, XRCC1 Arg194Trp, XRCC3 Thr241Met, APE1 Asp241Glu between lung cancer patients and controls for each polymorphism (p > 0.05). However, there was a significant difference between the genotype distributions of XRCC1 Arg399Gln, and PARP Val762Ala in patients and the control group (p > 0.05). Discussion: Only the polymorphisms of XRCC1 codon 399 and PARP Val762Ala alleles are associated with the risk of lung cancer. Other genotypes were not related to lung cancer.

Share and Cite:

Dingil, N. , Inan, Z. and Şentürk, A. (2022) Association between the DNA Repair Gene Polymorphisms and Lung Cancer in Turkish Population. Advances in Lung Cancer, 11, 15-29. doi: 10.4236/alc.2022.112002.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.